Maximus (MMS) Projected to Post Quarterly Earnings on Thursday

Maximus (NYSE:MMS) is anticipated to announce its Q3 2026 results before the market opens on Thursday, August 6th. Analysts expect Maximus to announce earnings of $2.21 per share and revenue of $1.3275 billion for the quarter. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Interested persons may visit the the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 9:00 AM ET.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the prior year, the company earned $2.01 earnings per share. Maximus’s revenue was down 4.1% compared to the same quarter last year. On average, analysts expect Maximus to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Maximus Trading Up 1.7%

Shares of MMS stock opened at $63.27 on Wednesday. The stock has a market cap of $3.32 billion, a P/E ratio of 9.47 and a beta of 0.59. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The business has a fifty day simple moving average of $58.75 and a 200-day simple moving average of $68.05.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s dividend payout ratio is presently 19.76%.

Analyst Upgrades and Downgrades

MMS has been the subject of several recent research reports. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Institutional Investors Weigh In On Maximus

Several hedge funds have recently modified their holdings of MMS. Parkside Financial Bank & Trust grew its holdings in shares of Maximus by 13.4% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after buying an additional 150 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares during the period. Larson Financial Group LLC boosted its position in Maximus by 13.8% during the third quarter. Larson Financial Group LLC now owns 1,869 shares of the health services provider’s stock worth $171,000 after acquiring an additional 227 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after acquiring an additional 304 shares during the last quarter. Finally, National Bank of Canada FI boosted its position in Maximus by 38.9% during the third quarter. National Bank of Canada FI now owns 1,118 shares of the health services provider’s stock worth $102,000 after acquiring an additional 313 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.